India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India-focused Independent Equity Research Analyst

Experienced (7 years +) in Sector-Specific Deep Dives and Comprehensive Company Research.

With a sharp focus on the Indian market, I specialize in providing in-depth analysis and insights to investors. Whether it's dissecting various sectors to identify emerging trends or conducting thorough fundamental research on individual companies, I'm dedicated to uncovering valuable opportunities and delivering actionable intelligence.

Passionate about navigating the nuances of the Indian equity landscape, I thrive on deciphering complex market dynamics and distilling them into clear, concise insights. 

While covering a sector or company-specific research, I cover the following :
1. Brief about company/sector
2.  Overall Industry landscape - History, Present and Future trends
3. Thesis and Anti-Thesis
4. Valuations
5. Financial & Forensic Analysis
6. Management Review
7. Key Monitorable Events
8. Guidance and Future Way Ahead

India Equity Analyst - Fundamental & Thematic

EV(E2W) Market Share War: Who Will Gain From the Consolidating Market?

How Falling Prices of Copra Are Reshaping India's FMCG Margins in 2026?

Renewable Energy Sector: EPS Growth Uncertainty?

Aether Industries: Leveraging Niche Expertise for Multi-Year Growth

Axis Bank: A Temporary Shock or A Structural Shift?

The Beat Ideas: Dixon Technologies ~ Revival or Ruin?

Event Driven: Coforge Acquisition ~ The Fall Analysis

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/kronox-lab-sciences-ltd" target="_blank" data-smartkarma-citation="entities:46205:1" rel="noopener">Kronox Lab Sciences Ltd (KRONOX IN)</a> specializes in manufacturing over 185 high-purity specialty fine chemicals, serving needs across pharmaceutical, biotech, and nutraceutical industries globally. </li>
<li>The upcoming Dahej facility, starting Phase 1 by December 2025, aims to diversify into nutraceuticals and is projected to contribute in generating INR 300 Crores revenue by FY27.</li>
<li>
Risks include stringent global purity standards, potential product rejections, geographic concentration in Gujarat, and the 18-month-long customer approval cycles required for new certified business.</li>
</ul>



Kronox Lab Sciences Ltd (KRONOX IN) specializes in manufacturing over 185 high-purity specialty fine chemicals, serving needs across pharmaceutical, biotech, and nutraceutical industries globally. 
The upcoming Dahej facility, starting Phase 1 by December 2025, aims to diversify into nutraceuticals and is projected to contribute in generating INR 300 Crores revenue by FY27.

Risks include stringent global purity standards, potential product rejections, geographic concentration in Gujarat, and the 18-month-long customer approval cycles required for new certified business.


Kronox Lab Sciences Limited: Unit-IV as a Strategic Breakout Catalyst?